Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Benef Microbes ; 11(5): 457-468, 2020 Sep 01.
Article in English | MEDLINE | ID: mdl-32865026

ABSTRACT

Pulses are dry leguminous crops consisting of beans, lentils, chickpeas, and peas. They are a broad category of food that are often aggregated when their contribution to healthy dietary patterns are disseminated. However, the different genera and varieties of pulses vary in composition and are consumed in different amounts, largely dictated by geographic region and ethnicity. Given the number of pulse-derived components, including fibre, that have the capacity to alter the composition of the gut microbiome, the objective of this study was to systematically review dietary pulses and pulse-derived ingredients as a broader food group, to determine their effect on gut microbiota in humans. Major scientific databases were used to conduct the search, which spanned from 1990 until February 2019. The search strategy identified 2,444 articles and five studies were included in this analysis. Two studies used whole pulses (chickpeas and pinto beans), one study used cooked navy bean powder, and the two remaining studies used pulse-derived fibre (lupin or yellow pea hulls). Although inconsistent, some studies demonstrated that whole pulses (pinto beans and chickpeas), cooked navy bean powder, and pulse-derived fibre (lupin kernel fibre), did impose changes to the microbiota that inhabit the human large intestine. However, there was considerable variability concerning the methodologies and endpoints used to decipher the observed effects on the abundance, diversity, and/or richness of specific microbiota or the microbiome. More extensive human studies that directly link the effects of specific types of pulses on the gastrointestinal microbial environment to health outcomes in the host are required.


Subject(s)
Diet , Dietary Fiber/metabolism , Fabaceae , Gastrointestinal Microbiome , Crops, Agricultural/metabolism , Feces/microbiology , Female , Humans , Male , RNA, Ribosomal, 16S/genetics , Randomized Controlled Trials as Topic , Vegetables
2.
Clin Microbiol Infect ; 26(9): 1254.e1-1254.e8, 2020 Sep.
Article in English | MEDLINE | ID: mdl-31404671

ABSTRACT

OBJECTIVES: Burkholderia pseudomallei, Yersinia pestis and Francisella tularensis are facultative intracellular bacteria causing life-threatening infections. We have (a) compared the activity of finafloxacin (a fluoroquinolone in development showing improved activity at acidic pH) with that of ciprofloxacin, levofloxacin and imipenem against the extracellular and intracellular (THP-1 monocytes) forms of infection by attenuated surrogates of these species (B. thailandensis, Y. pseudotuberculosis, F. philomiragia) and (b) assessed finafloxacin cellular pharmacokinetics (accumulation, distribution, efflux). METHODS: Bacteria in broth or in infected monocytes were exposed to antibiotics at pH 7.4 or 5.5 for 24 hr. Maximal relative efficacies (Emax) and static concentrations (Cs) were calculated using the Hill equation (concentration-response curves). Finafloxacin pharmacokinetics in cells at pH 7.4 or 5.5 was investigated using 14C-labelled drug. RESULTS: Extracellularly, all drugs sterilized the cultures, with finafloxacin being two to six times more potent at acidic pH. Intracellularly, Emax reached the limit of detection (4-5 log10 cfu decrease) for finafloxacin against all species, but only against B. thailandensis and F. philomiragia for ciprofloxacin and levofloxacin, while imipenem caused less than 2 log10 cfu decrease for all species. At acid pH, Cs shifted to two to five times lower values for finafloxacin and to one to four times higher values for the other drugs. Finafloxacin accumulated in THP-1 cells by approximately fivefold at pH 7.4 but up to 20-fold at pH 5.5, and distributed in the cytosol. CONCLUSIONS: Fluoroquinolones have proven to be effective in reducing the intracellular reservoirs of B. thailandensis, Y. pseudotuberculosis and F. philomiragia, with finafloxacin demonstrating an additional advantage in acidic environments.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia/drug effects , Fluoroquinolones/pharmacology , Francisella/drug effects , Yersinia pseudotuberculosis/drug effects , Humans , Hydrogen-Ion Concentration , Imipenem/pharmacology , Levofloxacin/pharmacology , Microbial Sensitivity Tests , Monocytes , THP-1 Cells
3.
Eur J Clin Nutr ; 71(5): 614-624, 2017 05.
Article in English | MEDLINE | ID: mdl-27804960

ABSTRACT

BACKGROUND/OBJECTIVES: It is unknown whether short sleep duration causatively contributes to weight gain. Studies investigating effects of partial sleep deprivation (PSD) on energy balance components report conflicting findings. Our objective was to conduct a systematic review and meta-analysis of human intervention studies assessing the effects of PSD on energy intake (EI) and energy expenditure (EE). SUBJECTS/METHODS: EMBASE, Medline, Cochrane CENTRAL, Web of Science and Scopus were searched. Differences in EI and total EE following PSD compared with a control condition were generated using the inverse variance method with random-effects models. Secondary outcomes included macronutrient distribution and resting metabolic rate. Heterogeneity was quantified with the I2-statistic. RESULTS: Seventeen studies (n=496) were eligible for inclusion in the systematic review, and 11 studies (n=172) provided sufficient data to be included in meta-analyses. EI was significantly increased by 385 kcal (95% confidence interval: 252, 517; P<0.00001) following PSD compared with the control condition. We found no significant change in total EE or resting metabolic rate as a result of PSD. The observed increase in EI was accompanied by significantly higher fat and lower protein intakes, but no effect on carbohydrate intake. CONCLUSIONS: The pooled effects of the studies with extractable data indicated that PSD resulted in increased EI with no effect on EE, leading to a net positive energy balance, which in the long term may contribute to weight gain.


Subject(s)
Energy Metabolism , Sleep Deprivation/epidemiology , Energy Intake , Humans , Non-Randomized Controlled Trials as Topic , Randomized Controlled Trials as Topic , Risk Factors , Weight Gain
4.
J Hum Nutr Diet ; 29(4): 401-4, 2016 08.
Article in English | MEDLINE | ID: mdl-27028560

ABSTRACT

One of the most recent food trends is the quest for products that provide 'sustained energy'; a term that is garnering considerable attention within the marketplace. Often, 'sustained energy' health claims are based on a food's post-prandial glycaemic response. However, are generalised health claims regarding 'sustained energy' valid when only supported by glycaemic response data? Without context, the short answer is: probably not. Health claims that link sustained energy to a glycaemic response, or any other attribute of a food or diet, require context to ensure that the public correctly interprets and experiences the claimed effect and is not misled in their quest for healthy foods that impose the desired physiological benefit.


Subject(s)
Diet Fads/adverse effects , Energy Drinks/adverse effects , Energy Intake , Fatigue/prevention & control , Food Packaging , Functional Food/adverse effects , Hypoglycemia/prevention & control , Consumer Advocacy , Diet, Healthy/economics , Energy Drinks/economics , Fatigue/economics , Food Packaging/ethics , Food Packaging/trends , Fraud/prevention & control , Functional Food/economics , Glycemic Index , Health Knowledge, Attitudes, Practice , Humans , Hyperglycemia/economics , Hyperglycemia/etiology , Hypoglycemia/economics , Nutritional Sciences/education
5.
Oncogene ; 34(13): 1718-28, 2015 Mar 26.
Article in English | MEDLINE | ID: mdl-24769897

ABSTRACT

ORCTL3 is a member of a group of genes, the so-called anticancer genes, that cause tumour-specific cell death. We show that this activity is triggered in isogenic renal cells upon their transformation independently of the cells' proliferation status. For its cell death effect ORCTL3 targets the enzyme stearoyl-CoA desaturase-1 (SCD1) in fatty acid metabolism. This is caused by transmembrane domains 3 and 4, which are more efficacious in vitro than a low molecular weight drug against SCD1, and critically depend on their expression level. SCD1 is found upregulated upon renal cell transformation indicating that its activity, while not impacting proliferation, represents a critical bottleneck for tumourigenesis. An adenovirus expressing ORCTL3 leads to growth inhibition of renal tumours in vivo and to substantial destruction of patients' kidney tumour cells ex vivo. Our results indicate fatty acid metabolism as a target for tumour-specific apoptosis in renal tumours and suggest ORCTL3 as a means to accomplish this.


Subject(s)
Apoptosis , Kidney Neoplasms/therapy , Organic Anion Transporters/genetics , Stearoyl-CoA Desaturase/physiology , Adenoviridae/genetics , Animals , Cell Transformation, Neoplastic , Cells, Cultured , Endoplasmic Reticulum Stress , Female , Humans , Kidney Neoplasms/pathology , Mice , Organic Anion Transporters/physiology , Protein Structure, Tertiary
6.
Vaccine ; 27(33): 4447-51, 2009 Jul 16.
Article in English | MEDLINE | ID: mdl-19490962

ABSTRACT

Burkholderia pseudomallei and Burkholderia mallei are gram-negative bacilli that are the causative agents of melioidosis and glanders, respectively. Both humans and animals are susceptible to both diseases. There is currently no vaccine available for the prevention of disease. We report the protective efficacy of heat-inactivated Burkholderia thailandensis, B. mallei or B. pseudomallei cells as vaccines against murine melioidosis and glanders. Immunisation with heat-inactivated B. pseudomallei cells provided the highest levels of protection against either melioidosis or glanders. These studies indicate the longer term potential for heat-inactivated bacteria to be developed as vaccines against melioidosis and glanders.


Subject(s)
Bacterial Vaccines/immunology , Burkholderia mallei/immunology , Burkholderia pseudomallei/immunology , Glanders/prevention & control , Melioidosis/prevention & control , Animals , Antibodies, Bacterial/blood , Female , Glanders/immunology , Hot Temperature , Melioidosis/immunology , Mice , Mice, Inbred BALB C , Vaccines, Inactivated/immunology
7.
J Food Sci ; 73(8): H195-200, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19019115

ABSTRACT

Platycodins, a group of saponin glycosides from Platycodon grandiflorum, are believed to possess anti-obesity and cholesterol-lowering properties. The aim of the present study was to investigate whether dietary platycodins affect plasma, hepatic, or fecal cholesterol concentrations, as well as cholesterol absorption and fractional synthesis rates in a dose-dependent manner. Golden Syrian hamsters (n= 45) were fed atherogenic (0.25% cholesterol) diets enriched with platycodins in the forms of either aqueous extracts (containing 0.3% to 0.5% of platycodins of diet mass) or crude saponins fractions (containing 0.9% to 1.0% of platycodins of diet mass) for 28 d. [3, 4](-13)C-cholesterol and (2)H2O tracers were administered on days 26 and 28 to assess cholesterol absorption and biosynthesis, respectively. After platycodin intervention, total cholesterol concentrations in plasma and liver were reduced (P < 0.05) by 13% to 28% and 41% to 79%, respectively, whereas cholesterol concentrations in feces were increased (P < 0.05) up to 2.5-fold compared to controls. Platycodin feeding increased (P < 0.001) cholesterol absorption up to 60%, but not cholesterol synthesis. These results suggest that platycodin-enriched diets can lower circulating and whole body cholesterol contents, and thus reduce the risk of cardiovascular diseases through mechanisms independent from cholesterol absorption or synthesis.


Subject(s)
Anti-Obesity Agents/administration & dosage , Anticholesteremic Agents/administration & dosage , Plant Extracts/administration & dosage , Platycodon/chemistry , Saponins/administration & dosage , Animals , Body Composition/drug effects , Cholesterol/analysis , Cholesterol/biosynthesis , Cholesterol/blood , Cholesterol, Dietary/administration & dosage , Cholesterol, Dietary/pharmacokinetics , Cricetinae , Deuterium , Energy Metabolism/drug effects , Erythrocytes/chemistry , Feces/chemistry , Kinetics , Lipids/blood , Liver/chemistry , Mesocricetus , Plant Roots/chemistry
8.
J Med Microbiol ; 56(Pt 8): 1005-1010, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17644705

ABSTRACT

Burkholderia pseudomallei is the causative agent of melioidosis, an infectious disease of humans and animals. Gene clusters which encode capsular polysaccharide (type I O-PS) and LPS (type II O-PS), both of which play roles in virulence, have previously been identified. Here, the identification of two further putative clusters, type III O-PS and type IV O-PS, is reported. Mice challenged with type III O-PS or type IV O-PS mutants showed increased mean times to death (7.8 and 11.6 days) compared to those challenged with wild-type B. pseudomallei (3 days). To investigate the possible roles of polysaccharides in protection, mice were immunized with killed cells of wild-type B. pseudomallei or killed cells of B. pseudomallei with mutations in the O antigen, capsular polysaccharide, type III O-PS or type IV O-PS gene clusters. Immunization with all polysaccharide mutant strains resulted in delayed time to death compared to the naïve controls, following challenge with wild-type B. pseudomallei strain K96243. However, immunization with killed polysaccharide mutant strains conferred different degrees of protection, demonstrating the immunological importance of the polysaccharide clusters on the surface of B. pseudomallei.


Subject(s)
Burkholderia Infections/microbiology , Burkholderia pseudomallei/pathogenicity , Genomic Islands/physiology , Polysaccharides, Bacterial/physiology , Vaccination , Virulence Factors/physiology , Animals , Bacterial Capsules/chemistry , Bacterial Capsules/genetics , Bacterial Vaccines/administration & dosage , Burkholderia Infections/prevention & control , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/immunology , Female , Genes, Bacterial/genetics , Immunization, Secondary , Injections, Intraperitoneal , Mice , Mice, Inbred BALB C , Multigene Family/genetics , O Antigens/genetics , Operon , Point Mutation , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...